Living with diabetes in America has long meant navigating unpredictable and often crushing insulin costs. Many patients have stood at the pharmacy counter wondering whether they could afford their next vial. Health policy experts have long argued that the U.S. insulin market allowed prices to rise far beyond what most families can reasonably manage. Now, California is attempting to disrupt that model with a bold plan to make insulin more affordable for residents.
